DeSci-focused DAO community funds cancer research
VitaDAO community agreed to fund early-stage cancer research through the launch of a biotech company named Matrix Biosciences.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
VitaDAO community agreed to fund early-stage cancer research through the launch of a biotech company named Matrix Biosciences.
Why this matters
This research story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
Federated Hermes Targets $14B Tokenized Fund Market With Prometheum Q1 2027 Launch
Key Takeaways: Federated Hermes and Prometheum are set to launch the first tokenized fund product in Q1 2027. Prometheum will dist...
Fission raises $10M to fix the exit problem in tokenized funds
Fission's innovation could significantly enhance liquidity in tokenized funds, potentially transforming investment dynamics and ma...
Specter links ProveX’s January ETH inflows to Heart-linked funds
The potential overstatement of external demand for ProveX could impact investor trust and raise concerns about transparency in cry...
DriveWealth Turns to Ripple’s RLUSD Stablecoin for Client Funding, With Europe First
DriveWealth, the company that runs the brokerage plumbing behind investing products offered by more than 100 partners worldwide, w...
Bitcoin ETFs shed $261M as XRP funds buck weekly outflow trend
Bitcoin ETFs have recorded $151 million in net outflows since Monday, after investors withdrew $681 million the previous week.
Kraken Parent Company Payward to Buy Saldo Bank in European Banking Push
Bitcoin Magazine Kraken Parent Company Payward to Buy Saldo Bank in European Banking Push Payward, the parent company of crypto ex...